Malignant Pancreatic Neoplasm — Trials

Malignant Pancreatic Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

3,630 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 904
Recruiting: 503
Ph III recruiting: 45
Growth YoY: +18.8%
Industry share: 32%
Top sponsor: National Cancer Institute (NCI)
Termination share: 34.5%
Trials / 1,000 deaths: 18.3 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (516)

clinicaltrialsPublishedShowing 401–450 of 632 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04716166	Incentive Spirometry and Upper Abdominal Laparoscopic Surgery	completed	N/A	60	Riphah International UniversityOTHER	1	Oct 20, 2021	clinicaltrials
NCT02245217	Multi-Tracer PET Prediction and Assessment of Response to Gemcitabine in Pancreatic Cancer Patients	completed	N/A	9	University of UtahOTHER	1	Oct 15, 2021	clinicaltrials